相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of sodium butyrate supplementation on reproductive performance and colostrum composition in gilts
B. He et al.
ANIMAL (2016)
Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice
Haixiao Li et al.
BRAIN RESEARCH (2016)
Involvement of 15-lipoxygenase-1 in the regulation of breast cancer cell death induced by sodium butyrate
Vahid Salimi et al.
CYTOTECHNOLOGY (2016)
C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21
Hao Wu et al.
DIABETOLOGIA (2016)
Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice
Umadevi Subramanian et al.
PHYSIOLOGICAL GENOMICS (2016)
Metallothionein plays a prominent role in the prevention nephropathy by sulforaphane via up-regulation of Nrf2
Hao Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion
Hui Liu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Metallothionein deletion exacerbates intermittent hypoxia-induced renal injury in mice
Hao Wu et al.
TOXICOLOGY LETTERS (2015)
Noninvasive In Vivo Imaging of Diabetes-Induced Renal Oxidative Stress and Response to Therapy Using Hyperpolarized 13C Dehydroascorbate Magnetic Resonance
Kayvan R. Keshari et al.
DIABETES (2015)
Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
Evan T. Hall et al.
DIABETES (2014)
Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats
A. Nihal Sari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats
Sabbir Khan et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis-a prospective randomized study
Lukasz Krokowicz et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome
T. Banasiewicz et al.
COLORECTAL DISEASE (2013)
Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?
Toshio Miyata et al.
KIDNEY INTERNATIONAL (2013)
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
Stacey Ruiz et al.
KIDNEY INTERNATIONAL (2013)
Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway
Vivian Soetikno et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
AMPK synergizes with the combined treatment of 1-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities
Keisuke Yaku et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
CurcuminuFrom Molecule to Biological Function
Tuba Esatbeyoglu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
Rubhana Raqib et al.
BMC INFECTIOUS DISEASES (2012)
Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
Ming-Zhi Zhang et al.
DIABETES (2012)
The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53
Keisuke Yaku et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Modification of Keap1 Cysteine Residues by Sulforaphane
Chenqi Hu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Nrf2 Activators as Attractive Therapeutics or Diabetic Nephropathy
Judy B. de Haan
DIABETES (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: Identification of functional antioxidant response elements on the Nox4 promoter
Srikanth Pendyala et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells
Matthew J. Kesic et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
Zhanguo Gao et al.
DIABETES (2009)
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
Xiaoqing He et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
SIRT1 Knockout Leads to Angiogenesis Deficiency in Adipose Tissue through Macrophage Dysfunction
Fen Xu et al.
DIABETES (2009)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy
L Cai et al.
DIABETES (2005)
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
D Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis - Randomized, double-blind, placebo-controlled pilot study
P Vernia et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
分享论文
